Cocrystal Pharma to Present at the Noble Capital Markets’ 21st Emerging Growth Equity Conference

3 weeks ago

BOTHELL, Wash., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that James…

Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions

3 weeks ago

BURLINGTON, Mass., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Neuphoria Therapeutics Inc. (“Neuphoria” or the “Company”) (NASDAQ: NEUP), a clinical-stage biotechnology…

INmune Bio Reports New Phase 2 Grey Matter Imaging Data at CTAD Conference Reinforcing XPro1595’s Evidence Base in High-Inflammation Alzheimer’s Patients

3 weeks ago

Boca Raton, FL, Dec. 01, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage biotechnology company developing inflammation…

Connect Strengthens Leadership Team with Promotion of Cait Kelly to Chief Strategy Officer

3 weeks ago

SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Connect, the premier nonprofit organization in San Diego’s innovation ecosystem dedicated to…

Zwanger-Pesiri Radiology Implements Konica Minolta Healthcare’s Bone Suppression Imaging Technology to Enhance Chest X-ray Diagnoses

3 weeks ago

Konica Minolta Healthcare Bone Suppression Imaging Bone Suppression Imaging from Konica Minolta suppresses the ribs and the clavicle from standard…

Cerevance to Participate in RBC Capital Markets 2025 Healthcare Private Company Conference

3 weeks ago

BOSTON, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cerevance, a clinical-stage biopharmaceutical company advancing multiple cell type-specific therapies for the treatment…

Ascentage Pharma to Host Webcast Highlighting Key Data from ASH 2025

3 weeks ago

ROCKVILLE, Md. and SUZHOU, China, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage…

Salarius Pharmaceuticals to Collaborate with Texas Biomedical Research Institute on Avian Flu Study

3 weeks ago

Salarius subsidiary Decoy Therapeutics’ influenza fusion inhibitors, designed using its proprietary IMP3ACT™ platform, show excellent in silico free energy binding…

Daré Bioscience Announces Return of Rights to Ovaprene®; Phase 3 Program Ongoing; Positive Interim Data and Grant Funding Position Asset for Value-Maximization

3 weeks ago

SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) --  Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused…

Catheter Precision Announces Launch of LockeT in Switzerland

3 weeks ago

Fort Mill, SC, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device…